Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
28.90
-0.52 (-1.77%)
Jun 17, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
Self-Produced Products | 379.99M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-Produced Products Growth | -0.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Purchased Products | 89.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Purchased Products Growth | -9.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service | 21.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service Growth | -12.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 129.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
In Vitro Diagnostics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Liquid-based Cytology Reagent | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Liquid-based Cytology Reagent Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Polymerase Chain Reaction Reagent | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Polymerase Chain Reaction Reagent Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Flourescence In Situ Hybridization Reagent | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Flourescence In Situ Hybridization Reagent Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Outsourcing Products - Reagents | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Outsourcing Products - Reagents Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Immunohistochemical Reagent | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Immunohistochemical Reagent Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Instruments | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-produced Product - Instruments Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Outsourcing Products - Instruments | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Outsourcing Products - Instruments Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
China | 490.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -2.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 323.92K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 74.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|